Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

FDA recall notice · announced September 20, 2017 · Chiavna Saffron

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

Reason for recall

Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

Notes

Distribution: Nationwide
Lot/code information: a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020
Quantity: 211 bottles; 339 boxes
Status: Terminated
Products in this recall event:
- Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY (D-1145-2017)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.